相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease
Arun J. Sanyal et al.
JOURNAL OF HEPATOLOGY (2023)
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD
Elizabeth M. Brunt et al.
JOURNAL OF HEPATOLOGY (2022)
MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis
Mazen Noureddin et al.
JOURNAL OF HEPATOLOGY (2022)
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
Ferenc Emil Mozes et al.
GUT (2022)
Nonalcoholic Steatohepatitis: Current Thinking From the Division of Hepatology and Nutrition at the Food and Drug Administration
Frank A. Anania et al.
HEPATOLOGY (2021)
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
Christina Adamichou et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis
Matt Docherty et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)
Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy-confirmed NAFLD
Gong Feng et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2021)
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
Annalisa Berzigotti et al.
JOURNAL OF HEPATOLOGY (2021)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip N. Newsome et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
Stephen A. Harrison et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
Beth A. Davison et al.
JOURNAL OF HEPATOLOGY (2020)
Handling missing predictor values when validating and applying a prediction model to new patients
Jeroen Hoogland et al.
STATISTICS IN MEDICINE (2020)
Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis
Jenny Lee et al.
PLOS ONE (2020)
Accurate Blood-Based Diagnostic Biosignatures for Alzheimer's Disease via Automated Machine Learning
Makrina Karaglani et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy et al.
CONTEMPORARY CLINICAL TRIALS (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis
Samuel J. Daniels et al.
HEPATOLOGY (2019)
Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients
Samar K. Darweesh et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
Evangelia Christodoulou et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH
J. Boursier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease
Toshifumi Tada et al.
BIOMARKERS (2018)
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential
Pierre Bedossa
LIVER INTERNATIONAL (2018)
The enhanced liver fibrosis (ELF) test in diagnosis and management of liver fibrosis
James W. Day et al.
BRITISH JOURNAL OF HOSPITAL MEDICINE (2018)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2015)
Validation of prediction models based on lasso regression with multiply imputed data
Jammbe Z. Musoro et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Serum Cytokeratin-18 Fragment Levels Are Useful Biomarkers for Nonalcoholic Steatohepatitis in Children
Ariel E. Feldstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
Sudeep Tanwar et al.
HEPATOLOGY (2013)
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Arun J. Sanyal et al.
HEPATOLOGY (2011)
A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
Zobair M. Younossi et al.
OBESITY SURGERY (2011)
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients
R. Anty et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
Mustafa S. Ascha et al.
HEPATOLOGY (2010)
Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines
Andrea Marshall et al.
BMC MEDICAL RESEARCH METHODOLOGY (2009)
Building Predictive Models in R Using the caret Package
Max Kuhn
JOURNAL OF STATISTICAL SOFTWARE (2008)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
V Ratziu et al.
GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Stochastic gradient boosting
JH Friedman
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2002)
分享论文
